Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts

Bibliographic Data

ID14729496
AuthorsWeicong Chen (0000-0003-2751-897X, Southern Medical University), Xuemei Yang (0009-0007-5350-9432, Southern Medical University), Jialing Sun (0000-0002-0227-6364, Guangzhou University of Chinese Medicine), Yuyao Chen (0000-0001-6458-1412, Southern Medical University), Wenting Zhao (0000-0001-8481-1297, Southern Medical University), Chunyu He (0000-0003-4281-8655, Southern Medical University), Haiyan An (0000-0002-3851-9663, Southern Medical University), Jie Pang (0009-0002-1789-7689, Southern Medical University), Wei Xu (0000-0002-4727-1540, Southern Medical University), Bin Wen (0000-0001-5784-0893, corresponding author), Haitao Sun (0000-0002-4359-0157, Nanfang Hospital, corresponding author), Songqi He (0000-0001-9565-4557, Nanfang Hospital, corresponding author)
Year2023
Volume301
Pages115825
Publication date2023-01-01
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2022.115825
PMID36240978
OpenAlexW4304811499
LanguageEN
Citations received1
References cited36

BJJP inhibits the progression of HCC through suppressing VEGF-A and HGF expression in CAFs by downregulating PDGFRβ signaling

Biology · Cancer · Growth factor · Hepatocellular carcinoma · Pill · Platelet-derived growth factor receptor · Receptor · Signal transduction · Cancer Mechanisms and Therapy · Liver Disease Diagnosis and Treatment · Liver physiology and pathology · Medicine · Cancer Research · Genetics · Internal Medicine · Oncology · Pharmacology

Tools

Open DOIOpen Access